Cargando…

Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer

BACKGROUND: The aim of this randomized controlled study was to determine whether octreotide (OCT) or scopolamine butylbromide (SB) was the more effective antisecretive drug controlling gastrointestinal (GI) symptoms due to malignant bowel obstruction (MBO) caused by advanced ovarian cancer. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Xingang, Wang, Peige, Li, Shikuan, Zhang, Guangyong, Hu, Sanyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372044/ https://www.ncbi.nlm.nih.gov/pubmed/25889313 http://dx.doi.org/10.1186/s12957-015-0455-3

Ejemplares similares

Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats
por: Malta, Ananda, et al.
Publicado: (2016)

Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series
por: Takeuchi, Ippei, et al.
Publicado: (2015)

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome
por: Iihara, Hirotoshi, et al.
Publicado: (2018)

Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges
por: Gonzalez-Ochoa, Eduardo, et al.
Publicado: (2022)

Clinical remission of an inoperable malignant insulinoma by the combination treatment with octreotide and everolimus
por: Akahori, Hiroshi
Publicado: (2019)

Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide
por: McCaffrey, Nikki, et al.
Publicado: (2020)

Hyoscine butylbromide induced psychosis: A case report
por: Lageju, Nimesh, et al.
Publicado: (2022)

Hyoscine-N-butylbromide induced ventricular tachycardia during ERCP
por: Ozaslan, Ersan, et al.
Publicado: (2014)

The effect of hyoscine n- butylbromide on labor progress: A systematic review
por: Mohaghegh, Zaynab, et al.
Publicado: (2020)

Role of octreotide in small bowel bleeding
por: Khedr, Anwar, et al.
Publicado: (2022)

Hyoscine butylbromide for colorectal polyp detection: prospective, randomized, placebo-controlled trial
por: dos Santos, Carlos Eduardo Oliveira, et al.
Publicado: (2017)

Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction
por: Bravington, Alison, et al.
Publicado: (2023)

Antiperistaltic effect and safety of l-menthol for esophagogastroduodenoscopy in the elderly with contraindication to hyoscine-N-butylbromide
por: Yang, Tsung-Chieh, et al.
Publicado: (2022)

Delayed small bowel octreotide response in patients with hereditary transthyretin amyloidosis
por: Jonas, Wixner, et al.
Publicado: (2015)

The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial
por: Qahtani, Nourah H Al, et al.
Publicado: (2011)

Immediate dilation of a tight or stenotic cervix by intra-procedural administration of hyoscine butylbromide: A clinical trial
por: Hadadianpour, Shiva, et al.
Publicado: (2019)

Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy
por: Forbes, Nauzer, et al.
Publicado: (2021)

The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review
por: Bravington, Alison, et al.
Publicado: (2022)

Percutaneous biliary drainage for obstructive jaundice in patients with inoperable, malignant biliary obstruction
por: Zerem, Enver, et al.
Publicado: (2022)

Mechanisms of hyoscine butylbromide to improve adenoma detection: A case-control study of surface visualization at simulated colonoscope withdrawal
por: East, James E., et al.
Publicado: (2015)

Scopolamine for Tremor
Publicado: (1909)

Scopolamine Not Hyoscine!
Publicado: (1907)

Scopolamine Hydrobromate
por: Hobbs, Arthur G.
Publicado: (1894)

Scopolamine as an Anaesthetic
Publicado: (1906)

Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study
por: Jansen, Jolien, et al.
Publicado: (2023)

Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
por: Tiberg, Fredrik, et al.
Publicado: (2015)

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

Inoperable Cancer
Publicado: (1901)

Best management of locally advanced inoperable breast cancer
por: Curigliano, Giuseppe, et al.
Publicado: (2013)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Bowel obstruction in advanced cancer
por: Ferraz Gonçalves, José António, et al.
Publicado: (2019)

Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer
por: Pálsdóttir, Kolbrún, et al.
Publicado: (2023)

A Symposium on Scopolamin
Publicado: (1905)

Scopolamin-Morphin Anesthesia
Publicado: (1905)

Scopolamin-Morphin Anesthesia
Publicado: (1905)

Small Bowel Obstruction due to Intestinal Xanthomatosis
por: Barrera-Herrera, L. E., et al.
Publicado: (2015)

Octreotide Uptake in Parathyroid Adenoma
por: Karaçavuş, Seyhan, et al.
Publicado: (2012)

A case of small bowel obstruction due to phytobezoars
por: Ali, Wadah Abdelazim Ahmed, et al.
Publicado: (2013)

Small Bowel Obstruction Due to Suprapubic Catheter Placement
por: Bonasso, Patrick C., et al.
Publicado: (2016)

Bowel Obstruction and Hydronephrosis Due to an Over-the-Scope Clip
por: Tung, William, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_27r5suiup86n8m66b7odlv0gdq